|
Contact
information:
Telephone: (514) 340-8307
e-mail address: mark.wainberg@mcgill.ca
website:
Recent
Publications:
Doualla-Bell F, Avalos A, Tendani G, Mine M,
Gaseitsiwe S, Ndwapi N, Novitsky VA, Brenner B, Oliveira M, Moisi D,
Moffat H, Thior I, Essex M, Wainberg
MA.
Impact of HIV-1 subtype C on drug resistance mutations in patients from
Botswana failing a nelfinavir-constraining regimen. Antimicrob Agents
Chemother. 2006 (Accepted for Publication)
Frankel FA, Marchand B, Turner
D, Götte, M, Wainberg MA.
Impaired rescue of chain-terminated DNA synthesis associated with the
L74V mutation in human immunodeficiency virus type 1 reverse
transcriptase. Antimicrobial Agents and Chemotherapy. 49: 2657-2664,
2005.
Roidan A, Warren OU, Russell RS,
Liang C, Wainberg MA.
A HIV-1 minimal gag protein is superior to nucleocapsid at in vitro
annealing and exhibits multimerization-induced inhibition of reverse
transcription. J Biol Chem. 280: 17488-17496, 2005.
|
